· Volume surge · RGC

Regencell Bioscience Holdings Ltd (RGC) loses 46.0% in one week

The retreat stands out because turnover expanded sharply while momentum measures remained weak.

Weekly market chart context for Regencell Bioscience with healthcare drug-development workspace elements.

Regencell Bioscience Holdings Ltd (RGC) closed at 6.480 USD in the latest weekly market data, extending a steep 52-week chart downturn. The stock is down -72.9% over four weeks and -79.0% over twelve weeks.

Trading activity reinforced the move, with 2,189,302 shares changing hands versus a 13-week average of about 751,158. Market Dynamics showed pressure at -1.46, Relative Strength was -72.5, and the trend state was inactive, leaving the evidence firmly negative.